Electrotherapy is the therapeutic application of electrical current to nerves, muscles, or soft tissue through skin-mounted or implanted electrodes. In medical devices, it covers modalities such as TENS, NMES, and interferential current, used for pain relief, muscle re-education, and functional stimulation, and it is developed and tested under IEC 60601-1 and IEC 60601-2-10 requirements.
What is electrotherapy?
Electrotherapy refers to a category of medical devices and treatment modalities that deliver controlled electrical current to the body for a therapeutic effect. The current is delivered non-invasively through surface electrodes on the skin or, in some applications, through implanted leads. Common modalities include transcutaneous electrical nerve stimulation (TENS) for pain management, neuromuscular electrical stimulation (NMES) for muscle activation, interferential current (IFC) therapy, and functional electrical stimulation (FES) for restoring movement after neurological injury.
In the device lifecycle, electrotherapy sits at the intersection of electronics design, human factors, and clinical need. Engineering teams set waveform parameters, electrode configuration, and safety cutoffs early because these choices determine both efficacy and risk. The output stage and electrode interface are usually the highest-risk subsystems and get the closest scrutiny during verification.
Why electrotherapy matters in medical device development
Electrotherapy devices apply current directly to a patient, so design errors have immediate physical consequences: skin burns from excessive current density, unintended muscle contraction, interference with implanted cardiac devices, or under-dosing that makes the device clinically useless. A poorly characterized output stage or a thin biocompatibility assessment can trigger a 510(k) additional information request, delay CE marking under EU MDR 2017/745, or lead to a field action after launch.
Cost and schedule risk follow the same pattern. Electrical safety testing under IEC 60601-1, particular requirements under IEC 60601-2-10, and EMC testing under IEC 60601-1-2 demand dedicated lab time, often across several iterations. Teams that treat these standards as a late-stage checklist rather than a design input tend to rework hardware after a failed test, which pushes submission timelines by months.
How electrotherapy devices work
An electrotherapy device generates a controlled electrical waveform and delivers it through an electrode interface, with a control system that limits output based on impedance, timers, and, on more advanced units, sensor feedback. The core subsystems are:
- Signal generator: produces the stimulation waveform (pulsed, biphasic, monophasic, or interferential), with adjustable frequency, pulse width, and amplitude.
- Output and isolation stage: applies patient isolation and current-limiting circuitry so a single fault cannot deliver an unsafe current, per the applied-parts isolation rules in IEC 60601-1.
- Electrode interface: surface pads, probes, or garment-integrated electrodes that set contact area and current density; electrode materials and any conductive gel are assessed under ISO 10993.
- Control and user interface: lets the clinician or patient set intensity, program, and duration, and is evaluated through usability engineering under IEC 62366-1.
- Monitoring and safety cutoffs: detect electrode disconnection, high impedance, or current spikes and stop or adjust output automatically.
Devices for nerve and muscle stimulation are evaluated against IEC 60601-2-10, layered on the general standard IEC 60601-1. Risk management runs throughout under ISO 14971, with attention to thermal injury, cardiac interference, and stimulation of unintended muscle groups. Devices with embedded or connected software follow IEC 62304. Design inputs, outputs, and V&V activity are documented in a design history file to satisfy FDA 21 CFR Part 820.30 and EU MDR technical documentation requirements.
Common challenges and best practices
Electrode contact is the most common source of field issues. Dry or poorly adhered electrodes raise impedance, concentrating current at smaller contact points and increasing burn risk. Teams address this by specifying electrode adhesive and gel properties tightly and by building impedance monitoring into the output stage rather than relying on labeling alone.
Waveform parameters are another frequent gap. Engineers sometimes validate a device at nominal settings but skip testing at the extremes of the intensity range, where patient variability in skin condition and electrode placement matters most. Testing across the full parameter range, against a representative spread of simulated tissue impedance, catches problems that nominal-only testing misses.
Usability is often underweighted relative to electrical performance. A device with correct output but a confusing intensity dial invites user error, a common root cause in electrotherapy complaint data. Formative and summative usability testing under IEC 62366-1, run early enough to shape the interface rather than just confirm it, catches these issues before they reach the field.
Software-controlled or app-connected devices need coordinated risk analysis. Because the software sets and enforces output limits, it should be developed and verified under IEC 62304 alongside the hardware, sharing a single risk file rather than running two disconnected ones.
How SJML helps with electrotherapy
SJML designs and manufactures electrotherapy platforms as part of its device engineering and manufacturing work, covering circuit design, embedded firmware, mechanical enclosure, and electrode interface development. In-house labs support IEC 60601 electrical safety, EMC, and reliability testing during development, so output and isolation characteristics are verified ahead of design transfer. Manufacturing capabilities include medical PCBA, system integration, and custom cable harness assembly. SJML’s QARA team supports risk management under ISO 14971, usability engineering under IEC 62366-1, and regulatory submissions across FDA and EU MDR pathways, and the company has experience with electrotherapy and rehabilitation device programs.
Talk to SJML’s engineering team →
Frequently asked questions
TENS targets sensory nerves to reduce pain perception, typically using lower current at higher frequency. NMES targets motor nerves to produce a visible muscle contraction, used for strengthening or re-education. Both use surface electrodes and similar hardware, but waveform parameters and the clinical claim differ, which affects classification and labeling.
Electrotherapy devices are typically evaluated under IEC 60601-1 for general electrical safety, IEC 60601-2-10 for particular requirements on nerve and muscle stimulators, and IEC 60601-1-2 for electromagnetic compatibility. Risk management follows ISO 14971, usability follows IEC 62366-1, and electrode materials are assessed under ISO 10993.
Yes, if current density, electrode contact, or output limits are not properly engineered and tested. Reported issues include skin burns from high-impedance contact, unintended muscle contraction, and interference with implanted cardiac devices. This is why devices go through electrical safety testing, biocompatibility assessment, and risk management before market clearance.
Classification depends on intended use and risk. Many TENS and NMES devices for pain relief fall under Class II in the US and Class IIa or IIb under EU MDR, requiring a 510(k) or a notified body technical file review. Devices for more invasive applications may carry a higher classification.
Related terms
- Neuromuscular Electrical Stimulation (NMES)
- Transcutaneous Electrical Nerve Stimulation (TENS)
- IEC 60601-2-10
- Usability Engineering (IEC 62366-1)
- Design Verification
